JP Patent

JP2004513920A — 循環器系疾患のためのレニン阻害剤を含む相乗的組合せ剤

Assigned to Novartis AG · Expires 2004-05-13 · 22y expired

What this patent protects

本発明は、式（Ｉ）【化１】を持つレニン阻害剤もしくはその薬学的に許容される塩を含む、組合せ剤に関する。

USPTO Abstract

本発明は、式（Ｉ）【化１】を持つレニン阻害剤もしくはその薬学的に許容される塩を含む、組合せ剤に関する。

Drugs covered by this patent

Patent Metadata

Patent number: JP2004513920A
Jurisdiction: JP
Classification: —
Expires: 2004-05-13
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.